QCDx LLC is a medical device company that designs, manufactures, and sells instruments, consumables and reagents for the detection of rare cells in the blood circulation. Our mission is to reveal circulating tumor cell heterogeneity early in cancer onset and throughout the disease trajectory to deliver precision cancer diagnosis that will guide the clinical oncologist to optimize treatment, monitor therapy, characterize metastasis and assess treatment toxicity.